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Developing Normal Placental Growth Curves using 2-D Ultrasound in a Zimbabwe 
Maternity Hospital 
 
Nhundu BJ, Galerneau F, Kliman HJ. Department of Obstetrics, Gynecology, and 
Reproductive Services, Yale University, School of Medicine, New Haven, CT.  
 
The placenta aids in providing nutrients and oxygen from the mother to the developing 
fetus. Using a validated tool to measure Estimated Placenta Volume (EPV) prior studies 
have shown a small EPV predicts low birthweight in pregnant women in US institutions. 
The aim of this study was to develop Estimated Placental Volume (EPV) normative 
curves for a population of women in Zimbabwe across a range of gestational ages. 
Additionally, to determine if low EPV measurements were predictive of IUFD or 
stillbirth. From January to June of 2019 a total of 150 women at Mbuya Nehanda 
Maternity Hospital in Harare Zimbabwe underwent obstetric ultrasound scans between 
11+0 to 38+ 6 weeks gestational age (GA). EPVs were calculated using the previously 
validated Merwins’ calculator. Analysis of EPV versus gestational age revealed a 
parabolic curve with the following best fit equation: EPV= (0.3923 GA – 0.000486 GA2)3 
Two participants had stillbirths associated with low EPV measurements. We conclude 
that placental volume increases throughout gestation in our cohort of Zimbabwean 
women and follows a predictable parabolic curve. With a larger patient cohort and more 
follow up EPV maybe a simple and cost-effective screen to identify women in low 
resource settings who are carrying fetuses at risk for intrauterine growth restriction, IUFD 
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Prenatal care is defined as preventative care provided to ensure the health of 
mother and fetus throughout the duration of pregnancy. The goal is to accurately 
determine gestational age, provide appreciate screening and testing at each gestational 
milestone thus mitigating risk for morbidity and ensuring continued evaluation until time 
of delivery. Access to prenatal care is dependent on the socioeconomical status differs 
drastically from low-middle income countries and high-income countries [1]. Prenatal 
care typical begins in the first trimester with frequency of visits determined by risk 
assessment of the mother and fetus. Typically, in high income countries prenatal visits 
occur every 4 weeks for the first 28 weeks and then every 2 weeks until 36 weeks of 
gestation. Weekly visits occur thereafter until delivery [2]. The World Health 
Organization (WHO) recommends pregnant mothers receive at least four antenatal visits 
[2]. 
 
The Landscape of Prenatal Care in Zimbabwe:  
 
The current study was conducted in Harare, Zimbabwe. Like many other sub-
Saharan African countries, Zimbabwe bears a heavy burden of high maternal, neonatal 
and child mortality when compared to countries in other regions of the world. The 
Maternal Mortality Ratio has continued to increase over the years, from 283 deaths per 
100,000 live births to 578 deaths per 100,000 live births in 2005. The Under-Five 
Mortality rate is currently 82 deaths per 1,000 live births, which shows an improvement 
when compared to 102 deaths per 1,000 live births in 1999 [3].  
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Zimbabwe is divided into 10 administrative Provinces, which are divided into 59 
Districts. Harare, the biggest Province is made up of urban districts unlike all the other 
Provinces which are comprised of both urban and rural districts [3]. Zimbabwe faces 
tremendous resource limitations and thus antenatal care best practices are guided by the 
Who Health Organization (WHO) toolkit for developing nations. This is a minimum 
package that a country can use to build an appropriate program that is best suited for its 
circumstances. All women are encouraged to book or register at their nearest clinic by 12 
weeks of pregnancy (first trimester). In sub-Saharan Africa only 69% of women book for 
Antenatal care (ANC), in Zimbabwe however that number is higher with over 90% of 
women booking. Of note this data also includes women presenting for one initial ANC 
visit without evidence of subsequent visits [3]. Reasons for non-registrations includes 
poor economic and psychological backgrounds. The Zimbabwean government has 
alleviated this by waiving user fees at rural and district hospitals.  
Early booking within the first trimester allows for accurate pregnancy dating and 
reducing the risk of post-term pregnancy. If dates are uncertain an ultrasound scan is 
recommended prior to 24 weeks for accurate dating. Initial visits are also an opportunity 
for sexually transmitted disease screening such as syphilis, anemia, HIV and UTIs [3]. 
Low risk women are recommended to be seen six times in every pregnancy in Zimbabwe 
which is higher than the 4 visits recommended by WHO. Zimbabwe instituted a six-visit 
minimum in order to maximize the opportunities to detect and manage intrauterine 
growth restriction. The two extra visits are scheduled for week 20-22 and at 40-41 weeks.  
Currently for low risk women intrauterine growth restriction is assessed by measurement 
of the symphysis-fundal height (SFH) in centimeters using a tape measure. A 
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measurement is done at every visit and recorded on a graph. Failure of an increase in 
SFH over two consecutive measurements or a single measurement below the 5th 
percentile for gestation is an indication for referral to a tertiary hospital [3-4].  
All women getting ANC in public hospitals get routine iron and folate 
supplementation throughout pregnancy with a known anemia prevalence of 25%. Routine 
tetanus and toxoid vaccination are given to all women with doses 4 weeks apart. All 
women living in malaria endemic areas are given malaria prophylaxis comprising of 3 
tablets of sulfadoxine, pyrimethamine at the first two ANC visits [3-4]. All women found 
to be HIV positive receive counselling with their partners. Currently highly active (triple) 
anti-retroviral therapy yields best results and is offered to expectant mothers in 
















Intrauterine Growth Restriction and Low Birth Weight  
Low birth weight (LBW) is regarded as an important predictor of public health 
and a measure of progress toward sustainable development goals (SDGs) in developing 
countries. According to the WHO about 17% of infants in the developing world were 
born with LBW with an average of about 13% of birth in sub-Saharan Africa [6]. WHO 
has set a threshold for LBW for international comparison at a birth weight of less than 2.5 
kg (5.5 lb). Studies have found that LBW babies are about 20 times more likely to die in 
infancy compared to normal birth weight (NBW) babies, and those who survive, share a 
greater burden of various physical and psychological complications, such as behavioral 
and cognitive disorders [6]. The resulting health-care expenditures are also higher for the 
surviving LBW babies. LBW can have an impact on the health outcomes of the infant but 
more so influences family planning decisions and decreased desire for future children. 
Some studies have suggested mothers of LBW infants have increased levels of stress and 
are more prone to depression [6]. Ultimately, LBW has far reaching socioeconomic 
consequences for families in the developing world. As such the WHO has committed to a 
30% reduction of LBW by the year 2025 [6]. A growing body of evidence has suggested 
utilization of antenatal care (ANC) is correlated to improved pregnancy outcomes. 
The Role of Ultrasound in Pregnancy  
 
Obstetric ultrasound scans have become routine in prenatal care and have been 
used in clinical practice for over 40 years in the high-income countries (HIC) and more 
recently in low to medium income countries (LMIC). The elements of the ultrasound 
examination vary depending on the gestational age of the fetus and the health of both the 
mother and the fetus. The American College of Obstetricians and Gynecologists, the 
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American College of Radiology, the American Institute of Ultrasound in Medicine, the 
Society for Maternal–Fetal Medicine, and the Society of Radiologists in Ultrasound have 
established standardized terminology for obstetric ultrasounds categorized into three as 
standard, limited and specialized [7-9].  
1. Standard—Evaluation of fetal presentation, amniotic fluid volume, cardiac 
activity, placental position, fetal biometry, and fetal number and anatomic survey. 
The maternal cervix and adnexa should be examined as clinically appropriate 
and when technically feasible.  
2. Limited—A limited examination is performed with a specific clinical concern, 
such as confirming cardiac activity in the setting of vaginal bleeding or confirm 
placental location during labor.  
3. Specialized—A detailed or targeted anatomic examination is performed when 
an anomaly is suspected on the basis of history, laboratory abnormalities, or the 
results of the limited examination or standard examination. Other forms of 
specialized examinations include fetal doppler ultrasonography, biophysical 
profile and fetal echocardiography. Other indications of a specialized 
examination include fetal growth restriction and multifetal gestation. 
The fetal anatomy survey typically occurs after 18 weeks’ gestation and includes a 
multitude of measurements [7-9]:  
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Head, Face, and Neck: lateral cerebral ventricles, choroid plexus, midline falx, 
cavum septum pellucidi, cerebellum, cisterna magna, and upper lip Chest: heart 
with four-chamber view and left and right ventricular outflow tracts  
Abdomen: stomach (presence, size, and situs), kidneys, urinary bladder, umbilical 
cord insertion site into the fetal abdomen, umbilical cord vessel number 
Spine: cervical, thoracic, lumbar, and sacral spine  
Extremities: legs and arms 
Fetal Sex: In multiple gestations and when medically indicated  
Serial assessment of fetal size by clinical methods such as fundal height is a low-cost, 
relatively reliable, and easy way to screen for fetal growth disturbances in most pregnant 
women. When a growth disturbance is suspected clinically or there is a medical or 
obstetric condition that increases the risk of a growth disturbance, ultrasonography is the 
modality of choice to identify abnormal fetal growth [7-9].  
Four standard fetal measurements generally are obtained as part of a complete obstetric 
ultrasound examination after the first trimester: 1) fetal abdominal circumference, 2) head 
circumference, 3) biparietal diameter, and 4) femur length. Fetal morphologic parameters 
can be converted to fetal weight estimates using published formulas and tables [7-9]. 
Contemporary ultrasound equipment calculates and displays an estimate of fetal weight 
on the basis of these formulas. Although all of the published formulas for estimating fetal 
weight show a good correlation with birth weight, the variability of the estimate is up to 
20% with most of the formulas [7-9] 
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Imaging the Placenta in Pregnancy  
The placenta has been shown to play a vital role in pregnancy by providing 
nutrients and critical oxygen to the fetus from the mother [10-14]. Much effort has been 
directed toward the detection and assessment of intrauterine growth restriction (IUGR). 
The many cases of IUGR have traditionally been subdivided into fetal, placental and 
maternal [12]. It is clear that a normally functioning placenta is critical for normal fetal 
growth and development. Adequate fetal growth depends on the efficient delivery of 
nutrients from the mother to the fetus and therefore requires normal uterine perfusion, 
normal transplacental exchange of nutrients and waste and normal umbilical perfusion. 
Placental thickness and volume have been used to predict chromosomal anomalies and 
diseases such as pre-eclampsia, thalassemia and other complications of pregnancy [13-
15]. Currently sonographic assessment of placental volume is time consuming and 
requires expensive technology. The best approaches have been done with three-
dimensional ultrasound measurements that require specialized training [16]. 
The relationship between small placental size and fetal complications was 
explored by Wolf et al. Their study of 18 pregnant patients between 16 and 20 weeks 
gestation, and estimated placental volume and fetal weight by ultrasound at regular 
intervals [17]. A plot of EPV vs GA showed a sigmoid relationship between placental 
volume and gestational age. Of the 19 patients 11 experienced adverse fetal outcomes in 
these patients, the EPV vs gestational age growth curve showed restricted placental 
growth. The authors concluded that placental growth restriction preceded fetal growth 
restriction and adverse events [17]. 
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Wolf et al. further explored a method to measure 3D placental ultrasound. This method 
involved imaging parallel slices of the placenta separated by a given distance and the 
corresponding area of each slice [18]. The resultant equation could only be applied to 
placenta upto 26 weeks’ gestation due to the large size of the placenta with increasing 
gestation [18]. Despite the mathematical strength of 3D ultrasound, the method required 
specialized software and enhanced imaging analysis. This made it difficult to utilize in a 
clinical setting and a simpler method was required for use in a clinical setting.  
Azpurua et al first described a novel technique using 2-dimensional ultrasound to 
measure estimate placental volume they were able to show that measurements of EPV 
were similar to actual placental weights at birth [19]. Arleo et al further validated this 
method of using 2D ultrasound and developed normative EPV growth curves from a 
cohort of patients at Weill Cornell Medical Center [20]. They measured the EPVs of 423 
patients across different gestational ages. They showed that with increasing gestational 
age the EPV increased in a parabolic relationship of these 423 patients 4 patients had an 
abnormally small EPV, they suggested such patients would be ideal candidates for 
demonstrating if EPV may be a useful tool for predicting adverse outcomes [21]. Further 
studies have been conducted by Isakov et al in a cohort of women at Yale New Haven 
Hospital. The study followed 366 participants to further validate EPV across a range of 
gestational ages. They showed that in that cohort EPV increased with gestation following 
a predictable parabolic curve [22]. Additionally, an analysis of birth weight outcomes 
showed women with EPVs of patients in the 50th percentile had 2.42 times the odds of 
having a newborn with a birth weight in bottom 50th percentile. Indicating a possible 
correlation of birth weight will low EPVs [22].  
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Statement of Purpose 
 
Currently placental volume is not assessed in the routine care of pregnant women, 
despite its importance in prenatal development, mainly due to the technical difficulties 
hindering placental volume measurements. Kliman Labs has developed and validated a 
simple method of calculating the EPV, which can be done routinely by any healthcare 
provider in less than one minute using only a simple ultrasound device. 
 
The study was conducted at Mbuya Nehanda Maternity Hospital in Harare 
Zimbabwe. The study aimed to establish a new standard in prenatal care by allowing 
pregnant women to know if their fetus is well nourished or at risk for unexpected and 
sudden demise using low cost 2D ultrasound to measure the volume of the placenta. This 
knowledge would empower caregivers to identify and intervene in cases where a low 
EPV would be the first indication of an IUFD.   
Research Aims:  
1. To develop population normative curves for EPV measurement in a cohort of 
Zimbabwean women and compare with normative curves from a cohort of women 
at Yale New Haven Hospital and Cornell Such normative data will form the basis 
for the generation of tables, which could be incorporated into future ultrasound 
devices. 
2. To evaluate the relationship between EPV and birthweight in women undergoing 
obstetrical ultrasound at Mbuya Nehanda Maternity in Zimbabwe. 
3. To determine if EPV measurements are predictive of adverse outcomes such as 
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Intra uterine fetal demise and still birth.  
Hypothesis:   
1. Normative curves from a cohort of Zimbabwean women are comparable to 
normative curves acquired from Yale New Haven Hospital and Cornell 
studies.  
2. Small EPV is associated with a statistically significant risk for low 
birthweight in Zimbabwean women  













Research Methods  
This prospective study was approved by the Yale University School of Medicine 
Human Investigation Committee (protocol number 0905005157) as well as the University 
of Zimbabwe Medical Research Council of Zimbabwe (protocol number ZW118).  
Patients with singleton pregnancies presenting for a routine prenatal visit and/or 
obstetric ultrasound at Mbuya Nehanda Hospital were enrolled in the study and informed 
written consent was obtained by researcher BN. Each patient was interviewed regarding 
their antepartum course and medical history sufficient to validate the inclusion and 
exclusion criteria.  
Inclusion Criteria:  
-Gestational age between 8 and 42 weeks by last menstrual period. 
-Singleton gestation 
-18 years old or greater 
Exclusion Criteria:  
-Rupture of membranes 
-Intramural fibroid 
-Placenta previa  
-Women in active labor who have not received an epidural/other analgesia  
-A pain score of four or greater based on the Wong-Baker Faces Pain Scale.  
Placental measurements were performed on 150 patients using the Philips Z 
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model 2D ultrasound machine by trained researcher BN. The placenta was imaged at the 
maximal cross section with the robe placed perpendicular to the base of the placenta. The 
width measurements were taken from the tip edge to the opposite tip edge. The Top apex 
point of the maternal surface placenta was then located. A line was then created from the 
apex point to the width line until it lies perpendicular to the width line. Lastly the 
thickness was measured by measuring form the top apex point to the fetal surface of the 
placenta. The thickness is always equal to (in the case of flax placenta) or less than the 
height line (Figure 1-3)  
 
Fig. 1. Diagram showing parameters measured to calculate estimated placental volume 





Fig. 2: Representative image of an anterior placenta. Image shows a crescent shaped 
placenta with baseline width, height and thickness measured.  
 
Fig. 3: A representative image of a flat placenta. The thickness and the height are the 
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same values for purposes of measuring the EPV.  
The ultrasound measurements themselves took an additional 1 to 2 minutes 
beyond the routine ultrasound performed for clinical. For each patient the following data 
was collected and recorded. Deidentifying study number, gestational age based on last 
menstrual period (LMP) or estimated date of delivery (EDD) as determined by first 
trimester ultrasound, date of birth as well as relevant serology (HIV, syphilis and GBS.). 
Neonatal outcomes collected were as follows (APGAR scores, birth weight, ICU stay and 
other complications). 
Each patient received at least one EPV measurement and a maximum of three 
EPV measurement at one visit. The EPV calculation was done using the Merwin’s 
calculator at a specific gestational age (Figure 4).The EPV measurements were averaged 
for each patient resulting in 150 data points.  
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Fig. 4: Mobile Screenshot of Merwin’s Calculator utilized for quickly calculating EPV 
and varying gestational ages. Data for width, height and thickness are inputted to 
generate an EPV in cc at a specific gestational age.  
For the participants who delivered at Mbuya Maternity Hospital the infant’s 




Data Analysis  
Using R version 3.3.2 statistical software, an Estimated Placenta Volume vs 
Gestational Age best fit curve was generated for the patient cohort from Zimbabwe. 
Additionally, an EPV vs GA curves was generated and compared to data previously 
obtained from the patient cohort from Yale New Haven Hospital. Subgroup analysis was 
performed on a subgroup of participants who delivered at Mbuya Nehanda Maternity and 
subsequently has birth weight data available. Statistical analysis and interpretation 

























The first research aim was to develop population normative curves between EPV and GA 
in a cohort of Zimbabwean women, and then to compare this to previously published set 
of EPV vs GA data from Yale New Haven Hospital and Weill Cornell Medicine.  
Aim 1: To develop population normative curves for EPV measurement in 
Zimbabwean women and compare with normative curves from the United States 
(Yale New Haven Hospital and Cornell). 
The normative curve showing the relationship between EPV and GA in Zimbabwean 
participants showed a parabolic relationship with the best following best fit equation 
(Figure 5):  
 
EPV= ( 0.3923 GA – 0.000486 GA2)3 
 
The 10th and 90th percentile were within +/- 1.01 standard error. The p-value was less 
than 2.2 x10-16 with an adjusted r2 of 0.983.  
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Fig. 5: Estimated Placenta Volume (cc) vs Gestational Age (weeks) showing a parabolic 






The comparative data from Yale participants following the same inclusion and exclusion 
criteria showed a parabolic relationship with the following best fit equation :  
EPV= ( 0.3724 GA – 0.000366 GA2)3 
 
A composite graph showing data from both the Zimbabwe and Yale cohort showed a 
similar trend in the data with increasing EPV with increasing GA (Figure 6). The Yale 
data has more 1st and 2nd trimester EPV as compared to more 3rd trimester reading in the 
Zimbabwean cohort. The difference is due to late presentation for imaging among 
Zimbabwean women as compared to participants at Yale New Haven Hospital.  
Both data sets had similar coefficients in the EPV equation indicating that the placenta 




Fig. 6: Estimated Placenta Volume versus (cc) Gestational Age (weeks) curves 
for Yale data set (blue) and Zimbabwean cohort (red).  
Aim 2: To evaluate the relationship between EPV and birthweight in a women 
undergoing obstetrical ultrasound at Mbuya Nehanda Maternity in Zimbabwe. 
We next looked at the women who delivered at Mbuya Nehanda Maternity 
hospital and had their birth records available to document birth outcomes. Of the 150 
women imaged for EPV measurements 19 women had complete birth records available 
for evaluation. Data collected included: date of delivery, birthweight and any adverse 
outcomes (included stillbirth and intrauterine fetal demise). EPV percentiles were 
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generated as per gestational age using the Merwin’s’ calculator. The birth weight 
percentile was determined using the already available normative curves for birth weight 
and gestational age at delivery.  In general, among the participants with available birth 
weight data women with small EPV percentile measurements for their gestational age had 
babies with small birth weights. Most women with babies weighing under 2500g 
(considered small for gestational age) had a low EPV measurements. Additional data is 



















EPV % Birth 





1 27.3 201 2.00 1650 10 live 
2 34.1 238 0.20 2700 10 live 
3 35.1 280 0.60 3700 60 live 
4 36.0 510 28.00 2720 10 Stillbirth  
5 36.0 535 34.00 3500 50 live 
6 36.1 458 16.00 2950 50 live 
7 36.4 247 0.10  2500 10 Stillbirth  
8 36.6 503 24.00 4320 97 live 
9 37.3 547 32.00 2400 3 live 
10 37.4 687 65.00 2510 10 live 
11 37.4 658 60.00 3300 20 live 
12 37.6 364 3.00 2870 20 live 
13 37.6 566 36.00 2600 10 live 
14 37.7 719 53.00 2996 20 live 
15 38.1 549 30.00 2950 20 live 
16 39.1 594 38.00 2510 3 live 
17 39.1 529 23.00 3200 20 live 
18 39.4 631 58.00 2940 3 live 





Aim 3: To determine if EPV measurements are predictive of adverse outcomes such as 
Intra uterine fetal demise and still birth.  
We next looked at the patients who reported adverse birth outcomes in our cohort 
of patients. Of the 20 patients with available birth outcomes two participants reported a 
stillbirth.  
The first a 38 year old G4P3 BMI 23.1 imaged at 36+4 weeks had a mean EPV 
measurement of 247cc (0.10%) follow up then showed the patient had a stillbirth at 38 
weeks with a baby weighing 2500g (10%) . The ratio of estimated fetal weight (EFW) 
and EPV was 10.81 indicating a critically low placental volume and placental size. The 
patient had no prior history of pregnancy losses with no known past medical history.  
The second participant a 30year old G3P2 BMI 28.6 imaged at 36 weeks had a 
mean EPV of 510cc (28%) follow up showed the patient had a stillbirth at 39 weeks with 
a baby weighing 2720g (10%). The EFW/EPV was 4.94 indicating a low placental 
volume and corresponding low placenta size. The patient had no past medical history.  
Our data set showed 2 stillbirths in a cohort of 150 which is consistent with the 
rate of stillbirth of 1 in 100 pregnancies per year in the United States. There is no 
available data for the rate of stillbirths among Zimbabwean women. In both cases the 












The current study explored the utilization of Estimated Placenta Volume as a 
screening tool for IUFD and still birth in an antenatal clinic in Zimbabwe. The initial aim 
was to develop normative curves for a cohort of pregnant women presenting to an 
antenatal clinic in Zimbabwe. The normative curves for EPV vs GA plotted showed a 
parabolic curve further validating the mathematical model presented by previous authors 
from data sets at Yale New Haven Hospital and Weill Cornell College [12]. This study is 
the first to show such a model for women in Zimbabwe measurements. In both cases the 
EPV measurements were low enough to red flag a patient for follow up. Of note both 
patients were initially imaged for EPV at 36 weeks and it has no available prior imaging 
to determine when the placenta volume had become low. Both cases illustrate the need 
for the potential of incorporating the EPV into clinical practice as a tool for screening for 
potential adverse outcomes.  
The current study shows that EPV measurements continue to be quick and easy to 
perform during routine prenatal ultrasound visits. A trained provider can effectively 
measure placenta volume within 2 minutes. This study was performed in a low resource 
setting clinic with a standard package 2D ultrasound machine. Unlike previous methods 
for determining placental volume obtaining 2D ultrasound images of the placenta and 
calculating EPV is fast requires minimum cost and training. A small EPV measurement 
could serve as an indicator to a health care provider of a fetus at risk. This information 
can then be utilized in further visits for serial EPV and fetal weight measurements. At 
present there is low clinical utility to a small EPV measurement in early pregnancy. Our 
study parameters initiated EPV measurements at 11 weeks gestation. A low percentile 
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EPV measurement in early pregnancy is best managed by serial EPV measurements. A 
consistently low EPV with increasing gestational age further warrants close follow up.  
The present study has several limitations. While we were able to recruit a large 
cohort of patients from the antenatal clinic most women did to not deliver at the 
maternity hospital and hence their birth weight data was not available to follow up for 
outcomes. Having more birthweight data would have increased the number of patients 
analyzed and increased the level of generalizability of the study in our population. 
Secondly most of our participants presented in their third trimester of pregnancy for 
ultrasound imaging making it difficult to measure large sized placentas and also for those 
placentas that were found to be small in size and opportunity to determine the chronicity 
of the placental volume defect.  
This study is the first to generate normative data on a population of pregnant 
women in Zimbabwe, with a larger patient cohort the data can be utilized to 
automatically flag abnormal placental size. Such normative data will form the basis for 
the generation of tables, which could be incorporated into future ultrasound devices. This 
will empower future caregivers to identify and intervene in cases where an IUFD or 
preterm delivery would have been the first indication of any problems. This method will 
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